Form 4 for TVGN Tevogen Inc.
Accepted 2025-07-01 00:00:00 ET · period of report 2025-06-27 · accession 0001062993-25-012331 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-01 | 2025-06-27 | TVGN | Khan Sadiq | Chief Commercial Off | A - Grant | $0.00 | +200.0K | 1.17M | +21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-27 | A | A | 200,000 | $0.00 | 1,169,618 | D | — | — | (F1) Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on June 27, 2030, provided that the reporting person remains in service with the Issuer at such dates. |